BEVAZZA 100MG INJECTION

About BEVAZZA 100MG INJECTION

Bevazza 100MG Injection contains bevacizumab 100mg. It blocks VEGF, a signal tumours use to grow new blood vessels, so the tumour is starved of blood supply, which is why it is classed as an anti-VEGF monoclonal antibody (targeted therapy). Specialists use it for metastatic colorectal cancer, non-small cell lung cancer, ovarian, cervical and kidney cancer, and glioblastoma. During treatment expect regular checks such as blood pressure and urine protein checks before each dose. Made by Lupin; pack size 1 vial (4ml). MRP Rs 7,480 as per the NPPA revision of 9 November 2026. Never start, stop or change it on your own - the oncologist or specialist decides the plan.